1 of 1
Story summary
- Candida auris, a drug-resistant fungus, has infected over 7,000 individuals in 27 U.S. states, according to the Centers for Disease Control and Prevention (CDC).
- The fungus poses a significant risk in healthcare settings, where it spreads rapidly among vulnerable patients.
- Its unique cell wall structure increases resistance to treatments, complicating diagnosis and containment efforts.
- Cases have been reported in 61 countries, highlighting its global virulence.
- Health officials stress the urgent need for better diagnostics, surveillance, and new antifungal treatments.
